By Walter F. Roche Jr.
One of the defendants in the criminal case triggered by the 2012 fungal meningitis outbreak has been transferred from a Massachusetts federal prison to a pre-release center in Philadelphia.
Federal Bureau of Prisons records show Gene Svirskiy has been transferred from the federal prison in Devens, Mass. to the federal Residential Re-Entry Center. He is scheduled for release on Aug. 26.
Svirskiy was sentenced to a 30-month prison term following his conviction on racketeering, conspiracy and mail fraud charges. Records in U.S. District Court in Boston, Mass. show Svirskiy plans to return to his home in Ashland, Mass.
Those records also show he is planning to go to work in a Massachusetts pharmacy headed by a member of the state Pharmacy Board.
Svirskiy is one of 14 indicted in late 2019 following a two-year probe of the fungal meningitis outbreak caused by drugs shipped from the New England Compounding Center, where Svirskiy was employed. He was not charged with producing the deadly drugs.
Under an agreement with the state Pharmacy Board Svirskiy was allowed to retain his license but with restrictions.
In a related development a federal judge has agreed to allow another NECC defendant, Barry Cadden, to file under seal a motion to oppose a proposal by federal prosecutors to nearly double his nine-year prison sentence.
U.S. District Judge Richard G. Stearns granted Cadden's request, which ensures that the details of Cadden's filing will not be publicly disclosed.
Contact: wfrochejr999@gmail.com
No comments:
Post a Comment